100% online and confidential. Compounded GLP-1 prescription medication delivered to your door.
No insurance needed. If a licensed provider doesn't approve you, you get a full refund.
Wegovy or Zepbound list price without insurance
published monthly prices at comparable telehealth clinics, July 2026
3-month plan; $99/mo on the 12-month plan
Compounded semaglutide prepared by a licensed 503A pharmacy under a prescription written for you. Not FDA-approved. Prices as displayed on each clinic's public site.
About 10 to 16 lbs typically comes off in the first 12 weeks as your dose builds.
Trial average over 68 weeks: 14.9% of body weight, about 30 lbs at your weight (NEJM, 2021).
No payment to start · Provider reviews every order
All prescribed by an independent US Board-certified physician and filled by a licensed Section 503A compounding pharmacy. Cancel anytime in one click.
Once-weekly injection · Dual-incretin
Dual-incretin therapy. Average 21% body-weight loss at 72 weeks in pivotal phase-3 trial. Compounded at a licensed 503A pharmacy.
(3-month plan) · as low as $179/mo on 12-month
Plan options · secure checkout
Same price at every dose.
Once-weekly injection · GLP-1
The most-studied GLP-1 compound. Average 15% body-weight loss at 68 weeks in STEP-1 trial. Compounded at a licensed 503A pharmacy.
(3-month plan) · as low as $99/mo on 12-month
Plan options · secure checkout
Same price at every dose.
Compounded medications are not reviewed or approved by the FDA but are prepared by licensed compounding pharmacies in compliance with Section 503A of the Federal Food, Drug, and Cosmetic Act. Prescription required from a licensed provider. Wegovy® and Ozempic® are registered trademarks of Novo Nordisk®. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company®. HealthRX.com is not affiliated with these companies.
"I'd tried every diet for a decade. The medication didn't make weight loss easier — it made it possible to act on what I already knew."
"The clinician actually answered my questions. The medication shipped overnight. I cancelled and re-started twice without anyone making it weird."
"Cheaper than Wegovy, ships faster than my old pharmacy, and the dose adjustments are included. I don't understand why anyone pays brand-name cash."
"I'm at 4 months. The titration schedule HealthRX.com uses matches the FDA label exactly. Side effects were mild after week two."
"I switched providers. The intake was faster, the support replies within hours, and they actually published their pharmacy's address."
"What sold me was the page about contraindications and the maintenance question. Everyone else hides those. These guys put them on the homepage."
Member reviews shown above are illustrative composites built from anonymized intake-to-outcome data; identifying details have been altered. Individual results vary. Compounded medications are not FDA-approved.
The most-asked question in obesity medicine. We answer it honestly, up front, because we'd rather you know now than after you've paid.
Roughly two-thirds of lost weight returns within 12 months of discontinuing semaglutide in published extension data. This is the body's setpoint reasserting itself, not a moral failure.
Obesity medicine is researching maintenance protocols: lower weekly dose, every-other-week, seasonal cycling. Your provider can prescribe a maintenance plan at goal weight.
Patients who pair the compound with structural behavior change — protein-prioritized eating, resistance training, sleep — retain more loss after taper.
GLP-1 medications have real contraindications per the FDA black-box label. We publish them here, before the consultation.
The same board-certified physicians and licensed 503A pharmacy, treating a few more things our patients ask about.
